Home » Category: 'Commercialization' (Page 2)

Commercialization

IP Osgoode Innovation Clinic, Norton Rose to participate in Accessibility Innovation Showcase

IP Osgoode Innovation Clinic, Norton Rose to participate in Accessibility Innovation Showcase

This article is cross-posted with permission from the author. To read the original post from Canadian Lawyer, click here. Law students from the IP Osgoode Innovation Clinic, in collaboration with lawyers from Norton Rose Fulbright Canada LLP’s IP group, will offer pro bono one-to-one intellectual property advice at an upcoming Ask the Expert program. The program takes place […]

#IPOsgoode #InnovationClinic to support inventors and entrepreneurs at 2017 Accessibility Innovation Showcase #OntarioAIS

#IPOsgoode #InnovationClinic to support inventors and entrepreneurs at 2017 Accessibility Innovation Showcase #OntarioAIS

IP Osgoode, the IP Osgoode Innovation Clinic, and Norton Rose Fulbright Canada LLP are pleased to announce their participation in the 2017 Accessibility Innovation Showcase’s Ask the Expert Program September 25 to 26 at The Sheraton Centre Toronto Hotel, 123 Queen Street West (at Bay Street), Toronto, ON. Members of the IP Osgoode Innovation Clinic […]

Broken Promises: Utility Standards and Patent Applications in Canada

Broken Promises: Utility Standards and Patent Applications in Canada

The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was whether the Promise Doctrine should be held as the correct standard of utility under the Patent Act. The SCC’s ruling finds the Promise Doctrine unsound […]

Connecting Canadians, Empowering Inclusive Innovation

Connecting Canadians, Empowering Inclusive Innovation

Innovation is, once again, a topic of great concern for Canadian policy makers and the commentariat. And for good reason. Yet, at a time when (mainly foreign) companies – notably Alphabet (Google), Apple, Tesla, Amazon, and Facebook – are lauded as being the ‘world’s most innovative’ (for example, see FastCompany and the Boston Consulting Group) […]

What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work

What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work

This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR genome editing system. Central to the talk was the evolving nature of genome editing technology and the ethical concerns that come with its growing breadth of […]

The Price for Pokemon - How Much Are Childhood Icons Worth Protecting?

The Price for Pokemon - How Much Are Childhood Icons Worth Protecting?

The Value of the Pokémon Franchise If you were born in the late 1980s or early 90s or have young children, you have probably encountered a red-cheeked mouse called Pikachu or any of the hundreds of other Pokémon that exist in the Pokémon media franchise. While the premise of catching colourful creatures is rather straightforward, […]

More Money, More Problems: The Science, the Law, and the Fight over CRISPR Patents

More Money, More Problems: The Science, the Law, and the Fight over CRISPR Patents

From Lab Bench to Court Bench: The Science, the Law, and the CRISPR Patent Dispute Whenever a new technology has the potential to be ground-breaking and extremely valuable, there are bound to be disputes about invention and ownership. From Nikola Tesla and Thomas Edison to the new space race, scientists and inventors are often driven […]

Do War Criminals Have Copyrights? The Role of Morality in Controversial Works

Do War Criminals Have Copyrights? The Role of Morality in Controversial Works

At first, a request for royalties by the estate of Nazi propagandist Goebbels was considered a joke by counsel for Random House. But the publisher now finds itself in the middle of a legal controversy after releasing a biography about the notorious World War 2 Nazi, which largely draws from Goebbels’s diaries.